Skip to content
Search
Search
About
Meet the team
Our guiding principles
News
Careers
Benefits
Company Culture
Optimer
®
platform
What is an aptamer?
Custom development workflow
Optimer
®
advantages
Optimer
®
libraries
Optimer
®
targets
Applications
Therapeutics
Bioprocessing
Assays and diagnostics
Knowledge centre
Articles
Customer case studies
Optimer
®
binders to license
Frequently Asked Questions
Partnerships
Investor Relations
Investor overview
Directors and advisers
Reports and presentations
Shareholder information
Regulatory news
Investor news email alerts
Corporate governance
Investor relations enquiries
Contact
Menu
About
Meet the team
Our guiding principles
News
Careers
Benefits
Company Culture
Optimer
®
platform
What is an aptamer?
Custom development workflow
Optimer
®
advantages
Optimer
®
libraries
Optimer
®
targets
Applications
Therapeutics
Bioprocessing
Assays and diagnostics
Knowledge centre
Articles
Customer case studies
Optimer
®
binders to license
Frequently Asked Questions
Partnerships
Investor Relations
Investor overview
Directors and advisers
Reports and presentations
Shareholder information
Regulatory news
Investor news email alerts
Corporate governance
Investor relations enquiries
Contact
Optimer
®
binders to license
Small molecule targets
Formyltetrahydrofolic acid
Folic Acid
Cortisol
Protein targets
Genetically detoxified Pertussis toxin
